This week, we take a "full breath" and dive into the Canadian cannabis sector, exploring two tech-focused companies that perfectly embody the industry's highs and lows.
Jon Brown looks at MediPharm Labs (TSX: LABS), a company successfully expanding its pharmaceutical-grade products globally, yet simultaneously embroiled in a public proxy battle with a dissident shareholder, forcing investors to weigh innovation against internal conflict. Then, Trevor Abes highlights Cannabix Technologies (CSE: BLO), a company diligently developing a first-of-its-kind marijuana breathalyzer, securing key partnerships and seeing its stock rise—all before booking its first dollar of revenue.
This Episode's Picks:
MediPharm Labs Corp. (TSX: LABS): A pharmaceutical cannabis company expanding its metered-dose inhalers to Europe while fighting a proxy battle that raises questions about governance and stability.
Cannabix Technologies Inc. (CSE: BLO): A pre-revenue technology pioneer that has achieved key testing milestones and a major manufacturing deal for its cannabis and alcohol breathalyzer.
Topics Discussed:
Further Reading & Resources:
Follow The Podcast:
Disclaimer: The material provided in this podcast is for information only and should not be treated as investment advice. For full disclaimer information, please visit themarketonline.ca/disclaimer.
Las Culturistas with Matt Rogers and Bowen Yang
Ding dong! Join your culture consultants, Matt Rogers and Bowen Yang, on an unforgettable journey into the beating heart of CULTURE. Alongside sizzling special guests, they GET INTO the hottest pop-culture moments of the day and the formative cultural experiences that turned them into Culturistas. Produced by the Big Money Players Network and iHeartRadio.
The Joe Rogan Experience
The official podcast of comedian Joe Rogan.
Stuff You Should Know
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.